Run With Purpose. Give With Heart.

by | Dec 28, 2022 | 0 comments

Run With Purpose. Give With Heart. Support HNF’s 2026 TCS New York City Marathon Team

Every step tells a story. This November, a courageous group of runners will take to the streets of New York City as part of the TCS New York City Marathon — running not just for themselves, but for the millions of people living with Charcot-Marie-Tooth disease (CMT) and other hereditary neuropathies.

Why We Run

CMT is the most common inherited neurological disorder, affecting approximately 1 in 2,500 people worldwide. It causes progressive muscle weakness, loss of sensation, and mobility challenges that impact everyday life. Despite its prevalence, CMT remains largely underfunded and underrecognized and that is exactly why we run.

Your Support Makes a Difference

Every dollar raised through our marathon team goes directly toward funding critical CMT research, advancing new treatments, and providing vital resources to patients and families navigating life with hereditary neuropathy. Together, we are getting closer to a cure.

How You Can Help

Make a donation — No amount is too small. Every contribution brings us one step closer to a world free of CMT

 

Learn more on this topic

Related Blog Posts

My last month in numbers

It has been entirely too long since I’ve updated my blog and so much has happened since late April. I thought I would share some info on what I’ve been up to since my last post on April 29th

March 29, 2015: OK…Now What?

March 29, 2015: OK…Now What?

January 15th 2015. That was the day I got my official invite to the race, that was the day of no turning back, that was the day I realized I was going to riding my bike a lot this spring and summer, a whole lot!

Breaking News: First Therapeutic Gene Therapy to Treat an Inherited Neuropathy is Approved for Clinical Trial!

The first disease community to receive a therapeutic gene to the spinal cord for an ultra rare inherited neuropathy is Giant Axonal Neuropathy (GAN). Congratulations to Hannah’s Hope Fund (HHF), a 501(c)3 public charity, which has driven this collaborative research in less than six years. Six million dollars has been raised to date to fund pre-clinical and clinical research on this rare disease.

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news